Physical Activity Capacity Assessment of Patients with Chronic Disease and the Six-Minute Walk Test: A Cross-Sectional Study
Abstract
Background: This study aimed to evaluate the efficacy of the Six-Minute Walk Test (6MWT) to determine the physical activity capacities of patients with chronic disease. Methods: For this cross-sectional study, we investigated 156 patients with chronic disease and no beta-blocker treatment. They systematically performed a maximal cardiopulmonary exercise test to determine their heart rate peak (HRPeak) and maximal oxygen uptake (V’O2max). We considered two groups of patients based upon the results of the functional evaluation of exercise performance: (1) No limitation in exercise performance (V’O2max greater or equal to 80% of the theoretical reference) and (2) limited exercise performance (V’O2max less than 80% of the theoretical value). All patients also received a 6MWT on the same day as the exercise test. Results: We found 68 (43.6%) patients with normal exercise capacities and 88 (56.4%) patients with limited exercise performance. In this sample, 6MWT mean distances were 510 (87) and 506 (86) m, respectively. There were no significant differences between the two groups for distance and end-test heart rate. The correlation between matrix V’O2max measured during the maximal incremental exercise test and the 6MWT distance displayed a positive slope (r = 0.549 CI95 [0.431–0.656]—p < 0.001). Conclusion: Our results showed a moderate relationship between 6MWT and physical activity capacity for patients with chronic disease.
Related
- Real intensity of physical activity capacity of patients with chronic disease: a cross-sectional study
- Vitality capacity association with lifelong aerobic physical activity in older adults
- Antidepressant medication use and objectively measured physical activity and sedentary behaviors in adults: A cross-sectional analysis of a nationally representative sample of Canadian adults
- Association of Halliwick-Based Aquatic Physical Activity with Health-Related Quality of Life in Children and Adolescents with Autism Spectrum Disorder: A Cross-Sectional Comparative Study.
- Impact of a 2-Year Structured Program on Physical Fitness and Physical Activity in T2D Patients with Rapid Renal Function Decline-the ACTIDIANE RCT
BibTeX
@article{allado2026physical,
title = {{Physical Activity Capacity Assessment of Patients with Chronic Disease and the Six-Minute Walk Test: A Cross-Sectional Study}},
author = {Edem Allado and Mathias Poussel and Eliane Albuisson and Jean Paysant and Margaux Temperelli and Oriane Hily and Anthony Moussu and Noura Benhajji and Gerôme Gauchard and Bruno Chenuel},
journal = {Healthcare},
year = {2026},
month = sep,
doi = {10.3390/healthcare10050758},
url = {https://hal.science/hal-04187900v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Physical Activity Capacity Assessment of Patients with Chronic Disease and the Six-Minute Walk Test: A Cross-Sectional Study
AU - Edem Allado
AU - Mathias Poussel
AU - Eliane Albuisson
AU - Jean Paysant
AU - Margaux Temperelli
AU - Oriane Hily
AU - Anthony Moussu
AU - Noura Benhajji
AU - Gerôme Gauchard
AU - Bruno Chenuel
PY - 2026
DA - 2026/09/02
JO - Healthcare
DO - 10.3390/healthcare10050758
UR - https://hal.science/hal-04187900v1
AB - Background: This study aimed to evaluate the efficacy of the Six-Minute Walk Test (6MWT) to determine the physical activity capacities of patients with chronic disease. Methods: For this cross-sectional study, we investigated 156 patients with chronic disease and no beta-blocker treatment. They systematically performed a maximal cardiopulmonary exercise test to determine their heart rate peak (HRPeak) and maximal oxygen uptake (V’O2max). We considered two groups of patients based upon the results of the functional evaluation of exercise performance: (1) No limitation in exercise performance (V’O2max greater or equal to 80% of the theoretical reference) and (2) limited exercise performance (V’O2max less than 80% of the theoretical value). All patients also received a 6MWT on the same day as the exercise test. Results: We found 68 (43.6%) patients with normal exercise capacities and 88 (56.4%) patients with limited exercise performance. In this sample, 6MWT mean distances were 510 (87) and 506 (86) m, respectively. There were no significant differences between the two groups for distance and end-test heart rate. The correlation between matrix V’O2max measured during the maximal incremental exercise test and the 6MWT distance displayed a positive slope (r = 0.549 CI95 [0.431–0.656]—p < 0.001). Conclusion: Our results showed a moderate relationship between 6MWT and physical activity capacity for patients with chronic disease.
SN - 2227-9032
ER -